发明申请
- 专利标题: DR5 LIGAND DRUG CONJUGATES
- 专利标题(中): DR5配对药物联合
-
申请号: US14389959申请日: 2013-04-23
-
公开(公告)号: US20150079114A1公开(公告)日: 2015-03-19
- 发明人: Toshiaki Ohtsuka , Kimihisa Ichikawa , Ayumi Yada
- 申请人: Seattle Genetics, Inc. , Daiichi Sankyo Co., Ltd.
- 国际申请: PCT/US13/37861 WO 20130423
- 主分类号: A61K47/48
- IPC分类号: A61K47/48 ; C07K16/28
摘要:
Ligand Drug Conjugates are provided having a DRS binding moiety attached via linking groups andor spacers to a therapeutic agent that are effective in treatment of various cancers. In some embodiments, the Ligand Drug Conjugate has the formula: L-(LU-D)p, where L is a Ligand unit, LU is a Linker unit and D is a Drug unit (or cytotoxic agent). The subscript p is an integer of from 1 to 20. Accordingly, the Ligand Drug Conjugates comprise a Ligand unit covalently linked to at least one Drug unit. The Drug units can be covalently linked directly or via a Linker unit (-LU-). The Ligand unit is a DR5 binding agent, such as an anti-DRS antibody.